Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health Inc. Class A

Insiders have been trading these 5 stocks: (($DELL)), (($HIMS)), (($U)), (($TMUS)) and (($LUV)). Here is a breakdown of their recent trades and the...

Insider Sales Shake Up Dell, Hims, Unity, T-Mobile, Southwest

Hims & Hers Health ($HIMS) is strengthening its position in the UK with the launch of weight-loss programs. This launch will also include the offic...

Hims & Hers Health (HIMS) Bolsters UK Business with Launch of Weight-Loss Plans

Hims & Hers Health ($HIMS) stock recently earned a new Buy rating from Barclays at a price target of $48. Barclays sees potential for over 20% upsi...

HIMS Stock Forecast: Barclays Initiates With Buy Rating, Sees Over 20% Upside

Analysts fell to the sidelines weighing in on Hims & Hers Health (HIMS – Research Report) and Cross Country Healthcare (CCRN – Research Report) wit...

Analysts Are Neutral on These Healthcare Stocks: Hims & Hers Health (HIMS), Cross Country Healthcare (CCRN)

Shares in telehealth company Hims & Hers Health ($HIMS) flowed higher today as it bought blood sampling business YourBio Health. Samples in Seconds...

M&A News: Him & Hers Snap Up ‘Pain Free’ Blood Testing Group YourBio

If you only glance at the share price, you might think the Hims & Hers Health ($HIMS) story has lost its spark. The stock has declined by more than...

Hims & Hers (HIMS) Investors Keep the Faith as Stock Slides 15%

Hims & Hers Health’s ($HIMS) shares continued to plunge on Thursday despite the consumer telehealth company launching a new “affordable” healthcare...

Current Quarter	$0.04	Next Quarter	$0.14
Current Year	$0.48	Next Year	$0.59
QoQ Growth	+250.0%	YoY Growth	+22.9%
3Y EPS CAGR	+44.2%	Target Price	$45.73
Consensus	Buy	Upside	+22.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HIMS	$37.21	-1.48%	10.28M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HIMS	$37.21	-1.5%	10.28M
3
4
5
6

HIMS

HIMS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Hims & Hers Health Inc. Class A Data in Excel

Get Hims & Hers Health Inc. Class A Data in Excel